Cite
Marzinke MA, Grinsztejn B, Fogel JM, et al. Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. J Infect Dis. 2021;224(9):1581-1592doi: 10.1093/infdis/jiab152.
Marzinke, M. A., Grinsztejn, B., Fogel, J. M., Piwowar-Manning, E., Li, M., Weng, L., McCauley, M., Cummings, V., Ahmed, S., Haines, C. D., Bushman, L. R., Petropoulos, C., Persaud, D., Adeyeye, A., Kofron, R., Rinehart, A., St Clair, M., Rooney, J. F., Pryluka, D., Coelho, L., Gaur, A., Middelkoop, K., Phanuphak, N., Cohen, M. S., Hendrix, C. W., Anderson, P., Hanscom, B., Donnell, D., Landovitz, R. J., & Eshleman, S. H. (2021). Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. The Journal of infectious diseases, 224(9), 1581-1592. https://doi.org/10.1093/infdis/jiab152
Marzinke, Mark A, et al. "Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083." The Journal of infectious diseases vol. 224,9 (2021): 1581-1592. doi: https://doi.org/10.1093/infdis/jiab152
Marzinke MA, Grinsztejn B, Fogel JM, Piwowar-Manning E, Li M, Weng L, McCauley M, Cummings V, Ahmed S, Haines CD, Bushman LR, Petropoulos C, Persaud D, Adeyeye A, Kofron R, Rinehart A, St Clair M, Rooney JF, Pryluka D, Coelho L, Gaur A, Middelkoop K, Phanuphak N, Cohen MS, Hendrix CW, Anderson P, Hanscom B, Donnell D, Landovitz RJ, Eshleman SH. Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. J Infect Dis. 2021 Nov 16;224(9):1581-1592. doi: 10.1093/infdis/jiab152. PMID: 33740057; PMCID: PMC8599849.
Copy
Download .nbib